Literature DB >> 1358741

Colorectal cancer risk and mortality in patients with ulcerative colitis.

E Langholz1, P Munkholm, M Davidsen, V Binder.   

Abstract

A regional inception cohort of 1161 ulcerative colitis (UC) patients was followed up from diagnosis to the end of 1987. The follow-up rate for death and occurrence of cancer was 99.9% (median observation time, 11.7 years; range, 0-26 years). One hundred forty-one deaths were observed, 26 caused by UC or complications thereof. No significant excess mortality was found after the first year, but in the year of diagnosis the relative risk of death was 2.4 (P < 0.001). The cumulative colectomy rate 25 years after diagnosis was 32.4%. The initial extent of disease significantly influenced the colectomy probability, being 35% in total colitis, 19% in substantial colitis, and 9% in distal colitis within the first 5 years after diagnosis. Six patients developed colorectal cancer within the observation period. Compared with the expected number of 6.6, the relative risk for patients with UC was 0.9. The calculated cumulative cancer incidence was 3.1% after 25 years (95% confidence limits, 0.0-6.8). The calculated lifetime risk (0-74 years) for development of colorectal cancer was 3.5% for UC patients compared with 3.7% for the Danish population. It is concluded that with an active approach to medical and surgical treatment, as practiced here, patients whose colons are left intact bear no significantly increased risk of colorectal malignancy.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358741     DOI: 10.1016/0016-5085(92)91163-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  88 in total

Review 1.  Cancer surveillance in inflammatory bowel disease.

Authors:  C N Bernstein
Journal:  Curr Gastroenterol Rep       Date:  1999-12

2.  Protagonist: Early surgical intervention in ulcerative colitis.

Authors:  R R Cima; J H Pemberton
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

3.  Antagonist: Early surgical intervention in ulcerative colitis.

Authors:  M A Kamm
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

4.  Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.

Authors:  C H Lim; M F Dixon; A Vail; D Forman; D A F Lynch; A T R Axon
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

Review 5.  [Differential indications for ileoanal pouch anastomosis : Ulcerative colitis, familial adenomatous polyposis, synchronous colorectal cancer - Crohn's disease, constipation].

Authors:  A Fürst
Journal:  Chirurg       Date:  2017-07       Impact factor: 0.955

Review 6.  Small bowel adenocarcinoma in Crohn's disease: a case report and review of literature.

Authors:  Irmgard E Kronberger; Ivo W Graziadei; Wolfgang Vogel
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

7.  Asymptomatic ileal adenocarcinoma in the setting of undiagnosed Crohn's disease.

Authors:  Vikram B Reddy; Harold Aslanian; Namsoo Suh; Walter E Longo
Journal:  World J Gastroenterol       Date:  2008-08-07       Impact factor: 5.742

Review 8.  Surgical treatment of ulcerative colitis in the biologic therapy era.

Authors:  Alberto Biondi; Marco Zoccali; Stefano Costa; Albert Troci; Ettore Contessini-Avesani; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

9.  Mortality Risk of Inflammatory Bowel Disease: A Case-Control Study of New York State Death Records.

Authors:  Angelica Nocerino; Alexandra Feathers; Elena Ivanina; Laura Durbin; Arun Swaminath
Journal:  Dig Dis Sci       Date:  2019-01-02       Impact factor: 3.199

10.  Ulcerative colitis: the fate of the retained rectum.

Authors:  Adam Juviler; Neil Hyman
Journal:  Clin Colon Rectal Surg       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.